Results 21 to 30 of about 324,602 (155)
Journal of Diabetes, Volume 15, Issue 12, Page 1048-1069, December 2023., 2023 Highlights We identified that CGM can increase motivation for self‐management and confidence in treatments. A supportive treating team may help to reduce the practical and psychological burden in patients with type 1 and type 2 diabetes. Abstract Aims Blood glucose control is central to the management of diabetes, and continuous glucose monitoring (CGM)
Patrizia Natale +10 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 12, Page 1011-1019, December 2023., 2023 Highlights Weight gain with insulin therapy in the early period may be negatively related to the occurrence and duration of remission by altering insulin sensitivity. Interventions to prevent rapid weight gain and conserve insulin sensitivity in the early stages of type 1 diabetes mellitus may be beneficial for the development and maintenance of ...
Dicle Canoruc Emet +9 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 12, Page 1070-1080, December 2023., 2023 Highlights Lipid profiles of small extracellular vesicles (sEVs) in patients with diabetes or diabetic cardiovascular disease are rarely reported. n‐3 docosahexaenoic acid (DHA)‐enriched triacylglycerol (TG) was found to decrease in sEVs from serum of patients with diabetic cardiovascular disease (DM‐CAD).
Wei Ding +3 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 11, Page 944-954, November 2023., 2023 Highlights Preclinical data showed that dipeptidyl peptidase‐4 inhibitors (DPP‐4is) may prevent insulin‐induced atherosclerosis. In patients treated with insulin for type 2 diabetes who underwent ≥2 serial coronary computed tomography angiographies(CCTA), a new obstructive coronary artery disease (OCAD) was less developed on the follow‐up CCTA in those
Young Choi +4 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 817-837, October 2023., 2023 Highlights Type 2 diabetes mellitus (T2DM) is characterized by progressive loss of beta‐cell function and mass. Numerous mechanisms of beta‐cell failure are involved. Preservation and/or enhancement of beta‐cell function is of great importance in delaying the progression of T2DM and the burden of its complications. Accurate evaluation of the effects of
Laure Sayyed Kassem +3 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 9, Page 777-786, September 2023., 2023 Highlights Increased glutamate is associated with the development of diabetes. Glutamate increases plasminogen (PLG) levels through glutamate metabotropic receptor 5 activation with various insulin resistance‐related stresses. Glutamate inhibits the conversion of PLG to plasmin by increasing plasminogen activator inhibitor‐1.
Hyo Jung Lee +7 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 9, Page 787-798, September 2023., 2023 Highlights Laparoscopic sleeve gastrectomy and laparoscopic Roux‐en‐Y gastric bypass are effective for reducing weight and improving metabolic parameters in Chinese patients with obesity. These interventions resulted in improved glycemic control, as evidenced by decreased glycated hemoglobin levels, reduced insulin resistance, and improved ...
Wenhuan Feng +6 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 8, Page 699-708, August 2023., 2023 Highlights This study is the first to evaluate the efficacy of the closed‐loop system MiniMed 780G in children aged 6 to 17 years with type 1 diabetes previously receiving continuous subcutaneous insulin infusion and intermittent continuous glucose monitoring. This shows early results, with improvement in time in range and all hyperglycemia times, from
Alfonso Lendínez‐Jurado +7 more
wiley +1 more source
Caveolin-3在白藜芦醇改善高脂诱导骨骼肌胰岛素抵抗中的作用
Zhongshan Daxue xuebao. Yixue kexue ban, 2012 【目的】在高脂诱导的胰岛素抵抗大鼠模型上，探讨微囊蛋白3（CAV-3）在白藜芦醇改善骨骼肌胰岛素抵抗中的作用及机制。【方法】实验大鼠分三组:正常饮食组（NORM），高脂饮食组（HFD），高脂饮食加白藜芦醇干预组（HFD+ RSV）。通过腹腔糖耐量试验，空腹血糖和空腹血清胰岛素值以及2-脱氧-[3H] 葡萄糖的摄取，从整体上探讨白藜芦醇对胰岛素抵抗的保护作用。再通过免疫印迹检验微囊蛋白3(CAV-3)与葡萄糖转运蛋白4（GLUT4）在以上过程中的表达情况。【结果】HFD能显著诱导胰岛素抵抗 ...
doaj +1 more source
A Review of micro RNAs changes in T2DM in animals and humans miRNAs在2型糖尿病人类和动物中的变化
Journal of Diabetes, Volume 15, Issue 8, Page 649-664, August 2023., 2023 Highlights MicroRNAs (miRNAs) are overexpressed in inflammation, insulin resistance, and type 2 diabetes mellitus (T2DM). Many types of miRNAs are changed during the T2DM progression. miRNAs have a potential role as a biomarker in T2DM diagnosis. Abstract Type 2 diabetes mellitus (T2DM) and its associated complications have become a crucial public ...
Mohammad Reza Afsharmanesh +3 more
wiley +1 more source